PrEP

Latest News

Drugs Commonly Used to Treat HIV and HBV May Reduce Immune Cells’ Energy
Drugs Commonly Used to Treat HIV and HBV May Reduce Immune Cells’ Energy

January 19th 2023

Tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF), antiretroviral drugs used to treat HIV and hepatitis B, may be simultaneously depleting the energy of immune cells.

NP and PA Network Opens its HIV Center of Excellence
NP and PA Network Opens its HIV Center of Excellence

December 20th 2022

Economic Impact of Genital Herpes Indicates Developing a Vaccine Should Be Top Priority
Economic Impact of Genital Herpes Indicates Developing a Vaccine Should Be Top Priority

December 19th 2022

COVID-19 Disrupted HIV Treatment, Prevention but Trend was Mostly Transient
COVID-19 Disrupted HIV Treatment, Prevention but Trend was Mostly Transient

December 16th 2022

Triumeq PD Positive Opinion Brings Europe Closer to Closing HIV Treatment Gap in Children
Triumeq PD Positive Opinion Brings Europe Closer to Closing HIV Treatment Gap in Children

December 16th 2022

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.